J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Batta, A. K.
Right arrow Articles by Shefer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Batta, A. K.
Right arrow Articles by Shefer, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 36, 2413-2418, Copyright © 1995 by Lipid Research, Inc.


ARTICLES

Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome

AK Batta, G Salen, GS Tint and S Shefer
Department of Medicine, University of Medicine and Dentistry-New Jersey Medical School, Newark, USA.

We have identified the third unknown sterol in the plasma and tissues of Smith-Lemli-Opitz homozygotes as 19-nor-5,7,9(10)-cholestatrien-3 beta-ol. The structure was established from capillary gas-liquid chromatography retention index and characteristic fragmentation pattern by mass spectrometry that were identical to a synthetic reference standard. Evidence is presented that 19-nor-5,7,9(10)-cholestatrien-3 beta-ol is not an artifact formed during the chemical isolation of the relatively unstable 7-dehydrocholesterol. It is possible that 19-nor- 5,7,9(10)-cholestatrien-3 beta-ol may contribute to the clinical abnormalities in patients with Smith-Lemli-Opitz syndrome.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
B. Lindenthal, T. A. Aldaghlas, J. K. Kelleher, S. M. Henkel, R. Tolba, G. Haidl, and K. von Bergmann
Neutral sterols of rat epididymis: high concentrations of dehydrocholesterols in rat caput epididymidis
J. Lipid Res., July 1, 2001; 42(7): 1089 - 1095.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. Ruan, W. K. Wilson, J. Pang, N. Gerst, F. D. Pinkerton, J. Tsai, R. I. Kelley, F. G. Whitby, D. M. Milewicz, J. Garbern, et al.
Sterols in blood of normal and Smith-Lemli-Opitz subjects
J. Lipid Res., May 1, 2001; 42(5): 799 - 812.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
R. D. Steiner, L. M. Linck, D. P. Flavell, D. S. Lin, and W. E. Connor
Sterol balance in the Smith-Lemli-Opitz syndrome: reduction in whole body cholesterol synthesis and normal bile acid production
J. Lipid Res., September 1, 2000; 41(9): 1437 - 1447.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
W. Gaoua, F. Chevy, C. Roux, and C. Wolf
Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: a model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome
J. Lipid Res., March 1, 1999; 40(3): 456 - 463.
[Abstract] [Full Text]


Home page
Arch. Dis. Child.Home page
P. T Clayton
Disorders of cholesterol biosynthesis
Arch. Dis. Child., February 1, 1998; 78(2): 185 - 189.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.